Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by Shierley

NVDA

Kevin Harrington Discusses FSD Pharma

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

April 13, 2023

USO

Kevin Harrington Discusses FSD Pharma

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

April 13, 2023

SPCE

Kevin Harrington Discusses FSD Pharma

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

April 13, 2023

NVDA

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

  FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On...

July 15, 2022

USO

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

  FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On...

July 15, 2022

SPCE

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

  FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On...

July 15, 2022

SPCE

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

June 3, 2022

USO

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

June 3, 2022

NVDA

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

June 3, 2022

NVDA

FSD Pharma Files Investigational New Drug Application “IND”

  FSD Pharma Files Investigational New Drug Application (“IND”) with...

June 2, 2022

USO

FSD Pharma Files Investigational New Drug Application “IND”

  FSD Pharma Files Investigational New Drug Application (“IND”) with...

June 2, 2022

SPCE

FSD Pharma Files Investigational New Drug Application “IND”

  FSD Pharma Files Investigational New Drug Application (“IND”) with...

June 2, 2022

SPCE

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

  FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets   ...

May 11, 2022

USO

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

  FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets   ...

May 11, 2022

NVDA

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

  FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets   ...

May 11, 2022

SPCE

Lucid-MS for Multiple Sclerosis Treatment

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

May 3, 2022

USO

Lucid-MS for Multiple Sclerosis Treatment

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

May 3, 2022

NVDA

Lucid-MS for Multiple Sclerosis Treatment

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

May 1, 2022

SPCE

"Julia Levy Award" Recipient David Allan and Dr. John McGraw

FSD Pharma Appoints Julia Levy Award Recipient David Allan and Dr. John...

April 26, 2022

USO

"Julia Levy Award" Recipient David Allan and Dr. John McGraw

FSD Pharma Appoints Julia Levy Award Recipient David Allan and Dr. John...

April 25, 2022

1 2 Next

Featured Company

Ucore Rare Metals Inc.

Ucore Rare Metals Inc. V.UCU

Ucore is focused on rare and critical-metal resources, extraction, beneficiation, and separation technologies with the ... view more »